HSIC vs. PDCO, TFX, DVA, QGEN, RGEN, PEN, UTHR, UHS, BIO, and SRPT
Should you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Patterson Companies (PDCO), Teleflex (TFX), DaVita (DVA), Qiagen (QGEN), Repligen (RGEN), Penumbra (PEN), United Therapeutics (UTHR), Universal Health Services (UHS), Bio-Rad Laboratories (BIO), and Sarepta Therapeutics (SRPT). These companies are all part of the "medical" sector.
Henry Schein vs.
Patterson Companies (NASDAQ:PDCO) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, community ranking, dividends, analyst recommendations, profitability and media sentiment.
Henry Schein has higher revenue and earnings than Patterson Companies. Patterson Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.
79.2% of Patterson Companies shares are owned by institutional investors. Comparatively, 93.3% of Henry Schein shares are owned by institutional investors. 1.5% of Patterson Companies shares are owned by insiders. Comparatively, 1.1% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Henry Schein received 2 more outperform votes than Patterson Companies when rated by MarketBeat users. However, 52.84% of users gave Patterson Companies an outperform vote while only 51.67% of users gave Henry Schein an outperform vote.
In the previous week, Patterson Companies had 16 more articles in the media than Henry Schein. MarketBeat recorded 20 mentions for Patterson Companies and 4 mentions for Henry Schein. Patterson Companies' average media sentiment score of 1.68 beat Henry Schein's score of -0.01 indicating that Henry Schein is being referred to more favorably in the news media.
Patterson Companies presently has a consensus target price of $35.83, indicating a potential upside of 21.43%. Henry Schein has a consensus target price of $84.00, indicating a potential upside of 14.90%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts clearly believe Patterson Companies is more favorable than Henry Schein.
Patterson Companies has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.
Henry Schein has a net margin of 3.64% compared to Henry Schein's net margin of 3.28%. Henry Schein's return on equity of 22.24% beat Patterson Companies' return on equity.
Summary
Henry Schein beats Patterson Companies on 10 of the 18 factors compared between the two stocks.
Get Henry Schein News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Henry Schein Competitors List
Related Companies and Tools